British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against...
from NDTV News - Latest https://ift.tt/3pn0S3o
No comments:
Post a Comment